Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial

Patients receiving oral anticoagulation (OAC) who undergo drug-eluting stent (DES) implantation require additional dual antiplatelet therapy with aspirin and clopidogrel. Such triple therapy confers an elevated bleeding risk, and its optimal duration is not known. The goal of this study was to evalu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2015-04, Vol.65 (16), p.1619-1629
Hauptverfasser:	Fiedler, Katrin A, Maeng, Michael, Mehilli, Julinda, Schulz-Schüpke, Stefanie, Byrne, Robert A, Sibbing, Dirk, Hoppmann, Petra, Schneider, Simon, Fusaro, Massimiliano, Ott, Ilka, Kristensen, Steen D, Ibrahim, Tareq, Massberg, Steffen, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Kastrati, Adnan, Sarafoff, Nikolaus
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aspirin - administration & dosage Aspirin - adverse effects Drug-Eluting Stents Female Humans Male Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!